clostridium difficileassociated diarrhea and colitis have emerged as major complications associated with use of systemic antimicrobialsin this study the medical records for 18 subjects who received donor stool by nasogastric tube for recurrent c difficile infection during a 9year period at a single institution were retrospectively reviewedduring the period between the initial diagnosis of c difficile colitis and the stool treatments the 18 subjects received a total of 64 courses of antimicrobials range 27 courses median 3 coursesduring the 90 days after receipt of treatment with stool 2 patients died of unrelated illnessesone of the 16 survivors experienced a single recurrence of c difficile colitis during 90day followupno adverse effects associated with stool treatment were observedpatients with recurrent c difficile colitis may benefit from the introduction of stool from healthy donors via a nasogastric tube